Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows (Unaudited)

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows from operating activities    
Net Loss $ (183,173) $ (239,904)
Adjustments to reconcile net loss to net cash used in operations:    
Amortization of Debt Discount 2,835 4,906
Accreted interest on Note Receivable (7,206)
Depreciation expense 40 40
Net loss from equity method investment 21,006 23,004
Unrealized Loss on Available-for-sale purchase 5,500 51,000
Change in Operating Assets and Liabilities:    
Interest Receivable (1,989)
Accounts Payable and Accrued Expenses 5,501 78,177
Accounts Payable and Accrued Expenses, related party 30,000 30,000
Net Cash used in Operating activities (127,486) (52,777)
Cash Flows from Investing Activities    
Notes Receivable (119,000)
Advance to a related party (17,500)
Net Cash used in Investing Activities (119,000) (17,500)
Cash Flow from Financing Activities    
Proceeds from short term advances, related parties 248,500 63,750
Net Cash provided by financing activities 248,500 63,750
Net cash increase (decrease) for the period 2,014 (6,527)
Cash beginning of the Period 5,632 9,184
Cash end of the Period 7,646 2,657
Supplemental disclosure for Cash Flow Information    
Cash paid for income taxes
Cash paid for interest expense 1,209
Supplemental disclosure for Non Cash investing and financing activities:    
Investment at Fair Value received from issuance of Note Receivable $ 43,000